Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
February 18, 2026 Off

Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference

By BusinessWire

MARSEILLE, France–(BUSINESS WIRE)–#Biotech–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), a clinical-stage biotechnology company…

February 18, 2026 Off

HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

By GlobeNewswire

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company…

February 18, 2026 Off

Flashpoint Therapeutics Announces Major Publication on Novel HPV Cancer Vaccine

By BusinessWire

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical…

February 18, 2026 Off

Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026

By BusinessWire

Conference Call to be Held at 4:30pm ET MIAMI–(BUSINESS WIRE)–$SMMT–Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will…

February 18, 2026 Off

Compass Pathways Launches Proposed $150.0 Million Public Offering

By BusinessWire

LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based…

February 18, 2026 Off

Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results

By BusinessWire

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…

February 18, 2026 Off

Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on…

February 18, 2026 Off

FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction

By BusinessWire

New FDA expansion of U.S. age indication extends EVO ICL use for patients 21 to 60 years old – making…

February 18, 2026 Off

Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3

By BusinessWire

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in TD Cowen’s 46th Annual Health Care Conference. Reshma Kewalramani,…

February 17, 2026 Off

GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness

By BusinessWire

CHICAGO–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical…

Posts pagination

Previous 1 … 6 7 8 … 6,330 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 19, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine